University of Oxford, United Kingdom
Disclosure information not submitted.
Comparing Safety and Effectiveness of Pfizer BA.4-5 and Sanofi bivalent COVID-19 Vaccines Used in the Spring 2023 Booster Programme in England: a Target Trial Emulation Study Using the OpenSAFELY Platform
Monday, August 26, 20241:30 PM – 1:45 PM CEST
Ursodeoxycholic acid and severe COVID-19 outcomes in people with liver disease: a cohort study using the OpenSAFELY platform
Tuesday, August 27, 20241:30 PM – 1:45 PM CEST
